2 growing ASX dividend shares named as buys

These dividend shares are growing at a solid clip…
The post 2 growing ASX dividend shares named as buys appeared first on The Motley Fool Australia. –

Although the shares listed below may not offer the largest yields on the market, they are growing at a solid rate. This could make them great long term options for patient income investors.

Here’s why analysts are rating them as buys right now:

Carsales.Com Ltd (ASX: CAR)

The first dividend share to look at is Carsales. It is a leading online advertising services company with a focus on the automotive industry. It generates its revenue predominantly from classified and display advertising. The former is from private sellers and dealer customers selling vehicles, whereas the latter is advertising from corporate customers such as finance and insurance companies.

It has been tipped for growth over the 2020s thanks to its dominant auto listings business in the ANZ market and its growing international operations. The latter will soon be boosted by the acquisition of a majority stake in US based Trader Interactive. It is a digital marketing solutions and services provider to the commercial truck, recreational vehicle, powersports, and equipment industries.

One broker that is positive on its prospects is Morgan Stanley. The broker currently has an outperform rating and $23.00 price target on its shares. This compares to the latest Carsales share price of $20.61. Morgan Stanley is forecasting dividends per share of 62 cents in FY 2021 and then 71.6 cents in FY 2022. This represents fully franked dividend yields of 3% and 3.5%, respectively.

Ramsay Health Care Limited (ASX: RHC)

Ramsay Health Care could be an ASX dividend share to consider. It is a global private healthcare company with facilities catering for a broad range of healthcare needs. This ranges from primary care to highly complex surgery, as well mental health care and rehabilitation.

The company is currently looking to add to its portfolio with the acquisition of Spire Healthcare. This morning Ramsay increased its offer in the hope of sealing a deal. If the takeover is a success, it is expected to create a leading private health care services provider in the lucrative UK market. It will also diversify its UK payor sources, case mix, expand the geographic reach of its capabilities, and improving capacity utilisation.

For now, though, Ramsay appears well-placed to benefit from a post-pandemic backlog in surgeries in the near term. This is expected to underpin solid earnings and dividend growth in the coming years.

Citi is bullish on Ramsay and currently has a buy rating and $76.00 price target on its shares. This compares to the latest Ramsay share price of $62.90. The broker is forecasting fully franked dividend yields of 2.4%, 3.3%, and then 3.6% over the next three financial years.

The post 2 growing ASX dividend shares named as buys appeared first on The Motley Fool Australia.

Should you invest $1,000 in Ramsay right now?

Before you consider Ramsay, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Ramsay wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of May 24th 2021

More reading

5 worst-performing ASX 200 healthcare shares of FY21

ASX 200 drops, Myer soars, Ramsay down

ASX 200 up 0.2%: Westpac asset sale, Ramsay increases Spire offer

Ramsay (ASX:RHC) share price lower on UK acquisition update
Wesfarmers (ASX:WES) reportedly looking to buy cancer care provider

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited and Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!